![Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article](https://assets.cureus.com/uploads/figure/file/240628/article_river_eddc5180e7e811ebbe70b79f4b23b4ca-diagram.png)
Cureus | Proton Pump Inhibitors: Exploring Cardiovascular Complications and Prescription Protocol | Article
![Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status - ScienceDirect Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508599701186-gr1.jpg)
Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status - ScienceDirect
![Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status - ScienceDirect Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508599701186-gr5.jpg)
Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status - ScienceDirect
![Rebound Effect: What Happens When Omeprazole Treatment Ends? - Paulick Report | Shining Light on the Horse Industry Rebound Effect: What Happens When Omeprazole Treatment Ends? - Paulick Report | Shining Light on the Horse Industry](https://paulickreport.com/.image/ar_1:1%2Cc_fill%2Ccs_srgb%2Cfl_progressive%2Cq_auto:good%2Cw_1200/MjAyMjM2OTgwNjQ5MjA2Nzk2/generic_horse.jpg)
Rebound Effect: What Happens When Omeprazole Treatment Ends? - Paulick Report | Shining Light on the Horse Industry
![Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-39335-7/MediaObjects/41598_2019_39335_Fig1_HTML.png)